Low doses of insulin-like growth factor-I induce mitochondrial protection in aging rats

Endocrinology

Volumn 149, Issue 5, 2008, Pages 2620-2627

  Puche, Juan E ^a,b   García Fernández, María ^b   Muntané, Jordi ^c   Rioja, José ^b   González Barón, Salvador ^b   Cortazar, Inma Castilla ^a,b  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

^b UNIVERSITY OF MÁLAGA   (Spain)

^c UNIVERSITY OF CÓRDOBA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADENOSINE TRIPHOSPHATASE; ATRACTYLOSIDE; CASPASE 3; CASPASE 9; CYTOCHROME C OXIDASE; SOMATOMEDIN C;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; LOW DRUG DOSE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATASES; AGING; ANIMALS; ANTIOXIDANTS; CASPASES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTRON TRANSPORT COMPLEX IV; HEPATOCYTES; INSULIN-LIKE GROWTH FACTOR I; MALE; MATRIX METALLOPROTEINASES; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTON PUMPS; RATS; RATS, WISTAR;

EID: 42449126697     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1563     Document Type: Article

References (42)

1. Sara VR, Hall K 1990 Insulin-like growth factors and their binding proteins. Physiol Rev 70:591-613
2. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S, Straume M, Iranmanesh A 1995 Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222
3. Ceda GP, Dall'Aglio E, Maggio M, Lauretani F, Bandinelli S, Falzoi C, Grimaldi W, Ceresini G, Corradi F, Ferrucci L, Valenti G, Hoffman AR 2005 Clinical implications of the reduced activity of the GH-IGF-I axis in older men. J Endocrinol Invest 28:96-100
4. García-Fernández M, Delgado G, Puche JE, González-Barón S, Castilla-Cortázar I 2007 10 January Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism and oxidative damage in aging rats. Endocrinology [Epub ahead of print]
5. Laron Z 1996 Short stature due to genetic defects affecting growth hormone activity. N Engl J Med 334:463-465
6. Wu A, Grant DB, Hambley J, Levi AJ 1974 Reduced serum somatomedin activity in patients with chronic liver disease. Clin Sci Mol Med 47:359-366
7. Castilla-Cortázar I, Prieto J, Urdaneta E, Pascual M, Nuñez M, Zudaire E, Prieto J 1997 Impaired intestinal sugar transport in cirrhotic rats: correction by low doses of insulin-like growth factor I. Gastroenterology 113:1180-1187
8. Castilla-Cortázar I, Garc?́a M, Quiroga J, Diez N, Diez-Caballero F, Calvo A, Diaz M, Prieto J 2000 Insulin-like growth factor I reverts testicular atrophy in rats with advanced liver cirrhosis. Hepatology 31:592-600
9. Cemborain A, Castilla-Cortázar I, Garc?́a M, Quiroga J, Muguerza B, Picardi A, Santidrian S, Prieto J 1998 Osteopenia in rats with liver cirrhosis: beneficial effects of IGF-I-treatment. J Hepatol 28:122-131
10. Castilla-Cortázar I, García M, Muguerza B, Perez R, Quiroga J, Santidrián S, Prieto J 1997 Hepatoprotective effects of insulin-like growth factor I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 113:1682-1691
11. Muguerza B, Castilla-Cortazar I, Garcia M, Quiroga J, Santidrian S, Prieto J 2001 Antifibrogenic effect in vivo of low doses of insulin-like growth factor-I in cirrhotic rats. Biochim Biophys Acta 1536:185-195
12. Pérez R, García-Fernández M, Castilla- Cortázar I, Quiroga J, Delgado G, González-Barón S, Prieto J 2001 Effect of IGF-I on mitochondrial dysfunction in rats with carbon tetrachloride-induced cirrhosis. J Hepatol 34:79
13. Kowaltowski AJ, Vercesi E 1999 Mitochondrial damage induced by conditions of oxidative stress. Free Radic Biol Med 26:463-471
14. Cardoso SM, Pereira C, Oliveira CR 1999 Mitochondrial function is differentially affected upon oxidative stress. Free Radic Biol Med 26:3-13
15. Earnshaw WC, Martins LM, Kaufmann SH 1999 Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424
16. Brand MD, Pakay JL, Ocloo A, Kokoszka J, Wallace DC, Brookes PS, Cornwall EJ 2005 The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem J 392(Pt 2):353-362
17. O'Connor JE, Vargas JL, Kimler BF, Hernandez-Yago J, Grisolia S 1988 Use of rhodamine 123 to investigate alterations in mitochondrial activity in isolated mouse liver mitochondria. Biochem Biophys Res Commun 151:568-573
18. Brand MD 1990 The proton leak across the mitochondrial inner membrane. Biochim Biophys Acta 1018:128-133
19. Barger JL, Barnes BM, Boyer BB 2006 Regulation of UCP1 and UCP3 in arctic ground squirrels and relation with mitochondrial proton leak. J Appl Physiol 101:339-347
20. Brand MD 1995 Measurement of mitochondrial proton motive force. In: Brown GC, Cooper CE, eds. Bioenergetics: a practical approach. Oxford, UK: Oxford University Press; 39-62
21. Monemdjou S, Kozak LP, Harper ME 1999 Mitochondrial proton leak in brown adipose tissue mitochondria of Ucp1-deficient mice is GDP insensitive. Am J Physiol 276(6 Pt 1):E1073-E1082
22. Bras M, Queenan B, Susin SA 2005 Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 70:231-239
23. Cortese JD, Voglino AL, Hackenbrock CR 1994 Persistence of cytochrome c binding to membranes at physiological mitochondrial intermembrane space ionic strength. Biochim Biophys Acta 1228:216-228
24. National Academy of Sciences 1991 The guiding principles for research involving animals. Washington, DC: National Institutes of Health
25. Arab K, Steghens JP 2004 Plasma lipid hydroperoxides measurement by an automated xylenol orange method. Anal Biochem 325:158-163
26. Miller NJ, Rice-Evans C, Davies MJ 1993 A new method for measuring antioxidant activity. Biochem Soc Trans 21:95S
27. Voss P, Siems W 2006 Clinical oxidation parameters of aging. Free Radic Res 40:1339-1349
28. Vieira HL, Haouzi D, El Hamel C, Jacotot E, Belzacq AS, Brenner C, Kroemer G 2000 Permeabilization of the mitochondrial inner membrane during apoptosis: impact of the adenine nucleotide translocator. Cell Death Differ 7:1146-1154
29. Halestrap AP, Woodfield KY, Connern CP 1997 Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase. J Biol Chem 272:3346-3354
30. Navarro A, Boveris A 2007 The mitochondrial energy transduction system and the aging process. Am J Physiol Cell Physiol 292:C670-C686
31. Ritz P, Berrut G 2005 Mitochondrial function, energy expenditure, aging and insulin resistance. Diabetes Metab 31:5S67-5S73
32. Kwong LK, Sohal RS 2000 Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse. Arch Biochem Biophys 373:16-22
33. Cortopassi GA, Wong A 1999 Mitochondria in organism aging and degeneration. Biochim Biophys Acta 1410:183-193
34. Mather M, Rottenberg H 2000 Aging enhances the activation of the permeability transition pore in mitochondria. Biochem Biophys Res Commun 273:603-608
35. Mirpuri E, Garcia-Trevijano ER, Castilla-Cortazar I, Berasain C, Quiroga J, Rodriguez-Ortigosa C, Mato JM, Prieto J, Avila MA 2002 Altered liver gene expression in CCl4-cirrhotic rats is partially normalized by insulin-like growth factor-I. Int J Biochem Cell Biol 34:242-252
36. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H 2001 IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 280:1191-1200
37. Tsujimoto Y 2003 Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195:158-167
38. Gu Y, Wang C, Cohen A 2004 Effect of IGF-1 on the balance between autophagy of dysfunctional mitochondria and apoptosis. FEBS Lett 577:357-360
39. Leinninger GM, Russell JW, van Golen CM, Berent A, Feldman EL 2004 Insulin-like growth factor-I regulates glucose-induced mitochondrial depolarization and apoptosis in human neuroblastoma. Cell Death Differ 11:885-896
40. Kondo T, Kitano T, Iwai K, Watanabe M, Taguchi Y, Yabu T, Umehara H, Domae N, Uchiyama T, Okazaki T 2002 Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ 9:682-692
41. Ness JK, Scaduto RC, Wood TL 2004 IGF-I prevents glutamate-mediated bax translocation and cytochrome c release in O4+ oligodendrocyte progenitors. Glia 46:183-94
42. Schneider WC, Hogeboom GH 1950 Intracellular distribution of succinoxidase and cytochrome oxidase activities in normal mouse liver and in mouse hepatoma. J Natl Cancer Inst 10:969-975